CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,431,111
- in 18 filings, $21.0M under 10b5-1 plans
Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Quinlan Paul T −$2.6M General Counsel sold 49% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2012-12-18 | BRISTOW MICHAEL R President and CEO | Grant or award | +517,116 | $0.48 | $250K | 834,495 |
| 2012-12-18 | BRISTOW MICHAEL R President and CEO | Grant or award · Common stock warrants (right to buy) | +387,837 | 387,837 | ||
| 2012-10-22 | FORMELA JEAN FRANCOIS Director | Grant or award | +317,379 | $0.39 | $125K | 1,579,542 |
| 2012-10-22 | FORMELA JEAN FRANCOIS Director | Grant or award · Common Stock Warrants (right to buy) | +238,034 | 313,483 | ||
| 2012-10-22 | ZABRISKIE JOHN L Director | Grant or award | +126,951 | $0.39 | $50K | 156,131 |
| 2012-10-22 | ZABRISKIE JOHN L Director | Grant or award · Common Stock Warrants (right to buy) | +95,213 | 95,213 | ||
| 2012-10-22 | BRISTOW MICHAEL R President and CEO | Grant or award | +317,379 | $0.39 | $125K | 317,379 |
| 2012-10-22 | BRISTOW MICHAEL R President and CEO | Grant or award · Common Stock Warrants (right to buy) | +238,034 | 238,024 | ||
| 2012-10-22 | Ozeroff Christopher David SVP and General Counsel | Grant or award | +63,475 | $0.39 | $25K | 105,233 |
| 2012-10-22 | Ozeroff Christopher David SVP and General Counsel | Grant or award · Common Stock Warrant (right to buy) | +47,606 | 47,606 | ||
| 2012-06-12 | BRISTOW MICHAEL R President and CEO | Conversion | +78,100 | 124,778 | ||
| 2012-02-10 | Grais Linda S Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2012-02-10 | Grais Linda S Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2012-02-10 | BREWER RICHARD B Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2012-02-10 | BREWER RICHARD B Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2012-02-10 | SOBEL BURTON E Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2012-02-10 | SOBEL BURTON E Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2012-02-10 | ZABRISKIE JOHN L Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2012-02-10 | ZABRISKIE JOHN L Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 | ||
| 2012-02-10 | FORMELA JEAN FRANCOIS Director | Grant or award · Option to Purchase Common Stock | +3,500 | 3,500 |
Page 27 of 41 · 802 trades